SM-020

· DermBiont, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SM-020, covering 2023-10-03 to 2023-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis [Phase 2]

See pricing